<!DOCTYPE html>
<html>
    <head>
        <meta charset="utf-8">
<meta http-equiv="X-UA-Compatible" content="IE=edge"/>
        <script src='echarts.min-4.8.0.js'></script>
        <script src='echarts-wordcloud.min.js'></script>
    </head>
    <body>
        <style>
            html, body, #main {
                width: 100%;
                height: 100%;
                margin: 0;
            }
        </style>
        <div id='main'></div>
        <script>
            var chart = echarts.init(document.getElementById('main'));
            var keywords = {"fine-needle aspiration":22,
"thyroid":141,
"lncRNA":8,
"miRNA":7,
"Breast cancer":62,
"Chemoresistance":4,
"Apoptosis":32,
"Invasion":26,
"Papillary thyroid cancer":77,
"Proliferation":36,
"cytopathology":7,
"Endoscopic thyroidectomy":13,
"Papillary thyroid carcinoma":286,
"Robotic thyroidectomy":5,
"Thyroid carcinoma":101,
"survival":31,
"thyroid lobectomy":10,
"total thyroidectomy":11,
"parathyroid adenoma":7,
"parathyroidectomy":3,
"Head and neck squamous cell carcinoma":8,
"Nasopharyngeal carcinoma":9,
"Oral squamous cell carcinoma":6,
"Radiotherapy":18,
"Follicular adenoma":4,
"Follicular neoplasm":6,
"Follicular thyroid carcinoma":21,
"Thyroid cancer":261,
"Thyroid gland":19,
"Ultrasonography":49,
"contrast-enhanced ultrasound":12,
"lymph node metastasis":36,
"ultrasound":52,
"Merkel cell carcinoma":5,
"differential diagnosis":9,
"immunohistochemistry":42,
"neuroendocrine":5,
"transcription factor":6,
"Thyroid nodule":73,
"Graves’ disease":6,
"Outcome":8,
"Radioiodine":13,
"Thyroidectomy":85,
"Central neck dissection":7,
"Safety":4,
"Vestibular approach":4,
"Chemotherapy":15,
"Guideline":5,
"Differentiated thyroid carcinoma":39,
"Cancer":48,
"ACR TI-RADS":4,
"thyroid nodules":33,
"Atypia of undetermined significance":4,
"Chronic lymphocytic thyroiditis":4,
"Thyroid malignancy":5,
"Thyroiditis":4,
"Thyroid surgery":11,
"Graves' disease":3,
"Hyperthyroidism":12,
"adjuvant":3,
"breast neoplasms":12,
"survivorship":4,
"Medullary thyroid carcinoma":64,
"PET/CT":6,
"cytology":25,
"diagnosis":33,
"lung metastasis":4,
"APC":3,
"WNT":4,
"epidemiology":19,
"pregnancy":5,
"Hypercalcemia":4,
"Reactive oxygen species":3,
"head and neck cancer":19,
"quality of life":10,
"Lymphoma":10,
"anaplastic thyroid cancer":11,
"chemoradiation":3,
"radiation":10,
"Prostate cancer":6,
"overdiagnosis":4,
"screening":4,
"Lenvatinib":16,
"tyrosine kinase inhibitor":14,
"Bethesda system":5,
"Circular RNA":4,
"neck dissection":17,
"Laser":4,
"DTC":3,
"PTC":22,
"TERT":10,
"lymph node ratio":4,
"lymph node yield":3,
"Papillary thyroid carcinoma (PTC)":19,
"fine-needle aspiration biopsy":5,
"histopathology":10,
"radioactive iodine":10,
"classification":5,
"malignancy":16,
"microRNA":15,
"progression":9,
"meta-analysis":23,
"risk of malignancy":6,
"Molecular testing":5,
"Frozen section":3,
"Thyroid neoplasm":15,
"Endocrinology":3,
"Nuclear medicine":5,
"Oxidative stress":4,
"Hürthle cell":4,
"fine-needle aspiration (FNA)":7,
"malignancy risk":3,
"Next generation sequencing":4,
"Anaplastic thyroid carcinoma":39,
"EMT":10,
"Machine learning":8,
"Magnetic resonance imaging":12,
"Radiomics":9,
"Active surveillance":15,
"BRAF V600E mutation":3,
"Papillary thyroid microcarcinoma":17,
"Prognosis":106,
"Risk stratification":7,
"autoimmunity":3,
"thyroid hormone":11,
"clinical practice guidelines":3,
"extrathyroidal extension":13,
"prognostic factors":6,
"bioinformatics":12,
"endocrine surgery":6,
"recurrent laryngeal nerve":6,
"risk factor":6,
"surgery":27,
"radioiodine therapy":9,
"PD-1":5,
"Triple-negative breast cancer":5,
"Selenium":3,
"thyroid neoplasms":87,
"thyrotropin":3,
"migration":21,
"thyroid papillary carcinoma":5,
"microarray":4,
"BRAF mutation":12,
"recurrence":44,
"medullary thyroid cancer":16,
"Exosome":7,
"Hepatocellular carcinoma":21,
"Noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP)":6,
"primary hyperparathyroidism":11,
"Korea":6,
"Parathyroid":4,
"Guidelines":7,
"Thyroid imaging reporting and data system":6,
"Immunotherapy":19,
"Pembrolizumab":4,
"TCGA":9,
"prognostic markers":3,
"renal cell carcinoma":10,
"IODINE RADIOISOTOPES":3,
"SORAFENIB":6,
"SYSTEMATIC REVIEW":6,
"Braf":26,
"Capsular invasion":6,
"Cáncer de tiroides":4,
"Molecular pathology":3,
"RAS":14,
"TP53":3,
"Vascular invasion":3,
"STAT3":5,
"cancer stem cells":3,
"cell proliferation":10,
"cisplatin":3,
"Lymph node dissection":10,
"Thyroglobulin":23,
"histology":5,
"incidence":11,
"mortality":11,
"survival analysis":6,
"trends":4,
"differentiated thyroid cancer":31,
"iodine-131":5,
"BRAF V600E":10,
"Thyroid function":5,
"Metastasis":41,
"papillary microcarcinoma":7,
"Biopsy, Fine-Needle":5,
"Core needle biopsy":5,
"Case report":28,
"Neuroendocrine tumor":4,
"Treatment":11,
"Hashimoto’s thyroiditis":6,
"Papillary carcinoma":19,
"Endoscopy":5,
"DNA methylation":9,
"biomarkers":12,
"Glycolysis":5,
"PKM2":5,
"magnetic resonance imaging (MRI)":4,
"therapeutic response":4,
"computed tomography":7,
"fine needle aspiration cytology":8,
"Follicular carcinoma":5,
"RET":12,
"Hashimoto thyroiditis":4,
"Goiter":6,
"thyroid ultrasound":7,
"thyroid hormones":3,
"Central lymph node dissection":3,
"follicular thyroid cancer":3,
"Biopsy":8,
"Fine-needle":3,
"Teratoma":3,
"c-Myc":3,
"Nivolumab":8,
"immune checkpoint inhibitor":3,
"metastatic thyroid cancer":3,
"fine-needle aspiration cytology":7,
"Hypocalcemia":8,
"conventional ultrasound":3,
"Propensity score matching":4,
"TERT promoter mutation":6,
"Child":4,
"Parathyroid carcinoma":8,
"lymph node metastases":5,
"distant metastases":6,
"thyroid-stimulating hormone":6,
"COVID-19":12,
"clinical trial":3,
"lung adenocarcinoma":7,
"metastatic carcinoma":4,
"Next-generation sequencing":4,
"Struma ovarii":5,
"nomogram":17,
"Neoplasm":5,
"Multifocality":4,
"Recurrence-free survival":6,
"Personalized medicine":3,
"Psammoma Bodies":4,
"β-catenin":3,
"HCC":5,
"forecasting":3,
"lymphatic metastasis":11,
"Pheochromocytoma":7,
"hyperparathyroidism":4,
"Esophageal cancer":3,
"Postoperative complication":4,
"diagnostic biomarker":4,
"long non-coding RNA":12,
"therapeutic target":5,
"Transoral robotic surgery":3,
"pathology":7,
"oncology":12,
"Transoral thyroidectomy":8,
"TOETVA":3,
"miR-195-5p":3,
"NIFTP":20,
"encapsulated follicular variant of papillary thyroid carcinoma":3,
"noninvasive follicular thyroid neoplasm with papillary-like nuclear features":6,
"obesity":8,
"MTC":4,
"lobectomy":12,
"follicular":5,
"biomarker":17,
"inflammation":7,
"P53":4,
"CASTLE":3,
"Metabolomics":3,
"Fine needle aspiration":8,
"Hemithyroidectomy":3,
"Indeterminate cytology":6,
"minimally invasive surgery":3,
"carcinoma":29,
"TTF-1":11,
"Lymph node":11,
"health care disparities":3,
"microRNAs":4,
"Adolescent":3,
"breast metastasis":4,
"lung cancer":9,
"PD-L1":9,
"resveratrol":3,
"Surgical treatment":5,
"Ablation":6,
"EGFR mutation":3,
"adenocarcinoma":6,
"lung":4,
"Computer-aided diagnosis":3,
"Deep learning":6,
"Gene expression":7,
"Cancer survivors":6,
"SEER":11,
"granular cell tumor":3,
"carcinoembryonic antigen":3,
"melanoma":5,
"Dog":3,
"age":8,
"distant metastasis":10,
"liquid-based cytology":5,
"immune cell infiltration":3,
"Elastography":3,
"Fibrosis":3,
"2020":8,
"Adult":8,
"Female":8,
"MRI":5,
"PET scan":3,
"Resection of tumour":3,
"TSH":5,
"Unique/unexpected symptoms or presentations of a disease":6,
"White":5,
"Bethesda":5,
"Non-invasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP)":4,
"carbon nanoparticles":3,
"parathyroid glands":3,
"Chernobyl":3,
"pediatric thyroid cancer":3,
"Subclinical hyperthyroidism":3,
"Thyrotoxicosis":3,
"Genetics":5,
"Surveillance":4,
"diagnostics":3,
"low risk":7,
"Anaplastic carcinoma":5,
"Laryngeal neoplasms":5,
"Shear wave elastography":5,
"TI-RADS":8,
"Second primary cancer":3,
"Overall survival":9,
"EGFR":3,
"salivary glands":3,
"larynx":5,
"neck":6,
"thyroid cytology":6,
"Medullary":3,
"Papillary":12,
"TIRADS":3,
"prognostic factor":3,
"Hypothyroidism":23,
"Laryngeal Cancer":4,
"Laryngectomy":4,
"Follicular variant of papillary thyroid carcinoma":5,
"Thyroid autoimmunity":3,
"DICER1":6,
"Polymorphism":3,
"pancreatic cancer":5,
"tumorigenesis":7,
"epithelial-mesenchymal transition":9,
"lncRNA PTCSC3":3,
"management":3,
"microcarcinoma":6,
"Angiogenesis":8,
"Tumor":4,
"endocrine":6,
"head and neck":6,
"Afirma":4,
"Minimally invasive":3,
"Multidetector computed tomography":3,
"Treatment outcome":5,
"BRAFV600E":11,
"Napsin A":3,
"Thyroid tumor":4,
"Prophylactic central neck dissection":3,
"Risk factors":20,
"FNA":12,
"Suspicious for malignancy":3,
"Radioactive iodine therapy":8,
"Response to therapy":3,
"Levothyroxine":10,
"Calcitonin":11,
"nodule":7,
"risk":4,
"neoplasms":10,
"Diffusion magnetic resonance imaging":3,
"Warburg effect":3,
"familial adenomatous polyposis":4,
"PTEN":5,
"thyroid dysfunction":3,
"Radiofrequency ablation":8,
"Thyroxine":3,
"SEER database":6,
"robotic surgery":3,
"Tumor size":5,
"autophagy":8,
"Differentiated thyroid carcinoma (DTC)":5,
"Tracheal resection":4,
"liver":3,
"Laryngeal carcinoma":4,
"Squamous cell carcinoma":12,
"Hypoparathyroidism":15,
"gender":3,
"Radiation therapy":4,
"Poorly differentiated thyroid carcinoma":7,
"diagnostic accuracy":4,
"lateral neck metastasis":3,
"vitamin D":4,
"pediatric":12,
"Liver metastasis":4,
"predictive factors":4,
"RET proto-oncogene":7,
"children":10,
"Molecular Biology":3,
"central lymph node metastasis":8,
"elderly patients":3,
"Anaplastic":4,
"Gastric cancer":9,
"NF-κB":4,
"RNA-Seq":3,
"iodine":6,
"Non-coding RNA":3,
"follicular thyroid adenoma":4,
"ACC, adrenocortical carcinoma":3,
"BLCA, bladder urothelial carcinoma":4,
"BRCA, breast invasive carcinoma":3,
"CESC, cervical squamous cell carcinoma and endocervical adenocarcinoma":3,
"CHOL, cholangiocarcinoma":3,
"COAD, colon adenocarcinoma":4,
"ESCA, esophageal carcinoma":4,
"GBM, glioblastoma multiforme":3,
"HNSC, head and neck squamous cell carcinoma":4,
"KICH, kidney chromophobe":3,
"KIRC, kidney renal clear cell carcinoma":3,
"KIRP, kidney renal papillary cell carcinoma":4,
"LAML, acute myeloid leukemia":3,
"LGG, brain lower grade glioma":3,
"LIHC, liver hepatocellular carcinoma":4,
"LUAD, lung adenocarcinoma":4,
"LUSC, lung squamous cell carcinoma":4,
"MESO, mesothelioma":3,
"OV, ovarian serous cystadenocarcinoma":3,
"PAAD, pancreatic adenocarcinoma":4,
"PCPG, pheochromocytoma and paraganglioma":3,
"PRAD, prostate adenocarcinoma":4,
"READ, rectum adenocarcinoma":3,
"SARC, sarcoma":3,
"SKCM, skin cutaneous melanoma":3,
"STAD, stomach adenocarcinoma":4,
"TGCT, testicular germ cell tumors":3,
"THCA, thyroid carcinoma":3,
"THYM, thymoma":3,
"UCEC, uterine corpus endometrial carcinoma":4,
"UCS, uterine carcinosarcoma":3,
"UVM, uveal melanoma":3,
"body mass index":4,
"Dysphagia":3,
"Toxicity":4,
"CT":3,
"peptide receptor radionuclide therapy":3,
"outcomes":3,
"RAI":3,
"hobnail variant":3,
"Hashimoto's thyroiditis":6,
"xenograft":3,
"lymph node metastasis (LNM)":5,
"childhood":3,
"SNP":4,
"TERT promoter":7,
"review":6,
"Breast":5,
"molecular marker":3,
"Hirschsprung disease":3,
"proteinuria":3,
"Adolescents":3,
"Tumor microenvironment":6,
"synchronous":3,
"CTLA-4":3,
"Multinodular goiter":3,
"Weighted gene co-expression network analysis":4,
"Neoplasm staging":6,
"thyroid diseases":3,
"Acromegaly":4,
"Colon cancer":3,
"ATC":4,
"apatinib":3,
"bioinformatics analysis":7,
"multiple endocrine neoplasia type 2":4,
"Hürthle cell carcinoma":3,
"Adenocarcinoma of lung":3,
"Neoplasm metastasis":4,
"Fine needle":3,
"SARS-CoV-2":3,
"brain metastasis":3,
"prediction":4,
"Long noncoding RNA":5,
"Paraganglioma":5,
"mutation":11,
"Hypertension":3,
"cabozantinib":3,
"tyrosine kinase inhibitors":4,
"Metabolism":4,
"MEN":3,
"Wnt/β-catenin pathway":4,
"CT scan":4,
"Fine needle aspiration biopsy":3,
"Sarcoidosis":4,
"Thyroid transcription factor-1":4,
"Thyroid ultrasonography":6,
"Lymph nodes":7,
"Colorectal cancer":4,
"Thyroid cancer, Papillary":5,
"Microarray analysis":3,
"Thermal ablation":5,
"Locoregional Recurrence":5,
"BRAFV600E mutation":5,
"Thyroid transcription factor 1":3,
"MicroRNA (miRNA)":3,
"Cervical lymph node metastasis":4,
"Adrenal":3,
"Head and neck neoplasms":7,
"paraneoplastic syndrome":3,
"imaging":3,
"AKT":3,
"PIK3CA":3,
"Acinic cell carcinoma":3,
"Salivary gland neoplasms":3,
"Osteosarcoma":3,
"Transoral":4,
"malignant struma ovarii":3,
"bone metastases":5,
"China":4,
"Immune checkpoint":3,
"Tissue microarray":5,
"Adjuvant therapy":3,
"Poorly differentiated thyroid cancer":4,
"circulating tumor DNA":3,
"The Cancer Genome Atlas":5,
"Otolaryngology":4,
"Fertility":3,
"Late effects":3,
"epigenetics":3,
"Ectopic thyroid tissue":3,
"metastatic":4,
"immune checkpoint inhibitors":4,
"Radionuclide therapy":3,
"Surgical procedures, operative":3,
"mitochondria":3,
"endocrine cancer":3,
"thyroid disease":3,
"Thyroid metastasis":3,
"disease-free survival":4,
"metastases":7,
"SMARCB1":3,
"thyroglossal duct cyst":3,
"prognostic biomarker":4,
"Surgical procedures, minimally invasive":4,
"Complications":3,
"BRAF gene":3,
"sporadic medullary thyroid carcinoma":3,
"Cell cycle":4,
"TNBC":3,
"mTOR":3,
"PI3k/Akt pathway":3,
"Hypophysitis":3,
"Thymoma":4,
"Lung neoplasms":3,
"non-small cell lung cancer":4,
"EZH2":3,
"Macrophage":3,
"Oncology: Endocrine":3,
"cytomorphology":3,
"neuroendocrine tumors":3,
"multiple endocrine neoplasia":4,
"intensity-modulated radiotherapy":3,
"Overtreatment":4,
"Bone":3,
"Risk of malignancy (ROM)":3,
"Diagnostic Imaging":4,
"sialadenitis":3,
"Morbidity":4,
"Pituitary":3,
"Telomerase":3,
"nodular goiter":3,
"tuberculosis":3,
"Retrospective study":3,
"epithelial–mesenchymal transition":3            };
            var data = [];
            for (var name in keywords) {
                data.push({
                    name: name,
                    value: Math.sqrt(keywords[name])
                })
            }
            var maskImage = new Image();
            var option = {
	             title: {
                text: '2020年论文keyword词云'
            },
                series: [ {
                    type: 'wordCloud',
                    sizeRange: [15, 100],
                    rotationRange: [-90, 90],
                    rotationStep: 45,
                    gridSize: 2,
                    shape: 'pentagon',
                    maskImage: maskImage,
                    drawOutOfBound: false,
                    textStyle: {
                        normal: {
                            color: function () {
                                return 'rgb(' + [
                                    Math.round(Math.random() * 160),
                                    Math.round(Math.random() * 160),
                                    Math.round(Math.random() * 160)
                                ].join(',') + ')';
                            }
                        },
                        emphasis: {
                            color: 'red'
                        }
                    },
                    data: data.sort(function (a, b) {
                        return b.value  - a.value;
                    })
                } ]
            };
            maskImage.onload = function () {
                option.series[0].maskImage
                chart.setOption(option);
            }
            maskImage.src = 'data:image/png;base64,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';
            window.onresize = function () {
                chart.resize();
            }
        </script>
    </body>
</html>
